TrialClinical cancer research : an official journal of the American Association for Cancer Research2012

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.

Sylvia Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.